Category Archives: IBS

IBS Impact’s Top 25 (or 33) Countries and Top 20 Posts of 2019

For the New Year, IBS Impact is once again participating in the common December-January blogger tradition of highlighting popular posts and interesting blog statistics from the year just past. This blog reached readers in 106 countries and territories during 2019. The cumulative total is 165 for the eight years WordPress has made country statistics available …

Continue reading

ProPublica Reporter Seeking to Interview People Taking Linzess (Linaclotide) for IBS-C, November 2019

IBS Impact is posting this opportunity on behalf of the journalist. If you are interested, please contact her directly at the email or phone number below. ProPublica is a reputable, bipartisan online investigative journalism website within the U.S. “Have you been prescribed Linzess? If so I’d like to talk to you! I’m a reporter with …

Continue reading

Veterans with IBS and Functional Gastrointestinal Disorders 2019

Today, November 11, is Veterans Day in the U.S. ,a federal holiday. It is also the traditional day on which many entities highlight veterans’ issues. U.S. veterans and current military service members who have been deployed in the Persian Gulf/Southwest Asia and Afghanistan regions at any time since 1990 have been shown by multiple studies …

Continue reading

Rep. Vela of Texas and Rep. Lee of Nevada Co-Sponsor Functional Gastrointestinal and Motility Disorders Research Enhancement Act (HR 3396)

According to IFFGD and the official Congressional legislative database Congress.gov, at the end of October 2019, Representative Filemon Vela (D-TX-34) and Representative Susie Lee (D-NV-3)  have added their support as a co-sponsors for HR 3396, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019. IBS Impact thanks them for taking the time to …

Continue reading

Updates to IBS Impact.com Main Website, October 2019

IBS Impact has recently completed the latest round of updates to many pages of our main website,  IBS Impact.com, The advocacy page, research page, IBS studies page, resources page, family and friends page,ibs and children page, and links page, several articles on subpages, plus the news updates in the blue and white footers of every …

Continue reading

Rep. Loebsack of Iowa Co-Sponsors Functional Gastrointestinal and Motility Disorders Research Enhancement Act (HR 3396)

According to IFFGD and the official Congressional legislative database Congress.gov, in the last week, Representative Dave Loebsack (D-IA-2)  has added his support as a co-sponsor for HR 3396, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019. This is the third time in different Congresses that he has supported versions of the Act, …

Continue reading

Functional Gastrointestinal and Motility Disorders Research Enhancement Act (HR 3396) Gains Bipartisan Support of 4 New Co-Sponsors From 4 New States

According to IFFGD and the official Congressional legislative database Congress.gov, so far in September 2019, four members of the U.S House of Representatives have added their support as co-sponsors for HR 3396, the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019. They represent both political parties and four different states new to the …

Continue reading

U.S. FDA Approves Tenapanor (Ibsrela) for Adults with IBS with Constipation (IBS-C)

This past week, the U.S Food and Drug Administration (FDA) approved the sale and distribution of a new medication for irritable bowel syndrome with constipation (IBS-C), tenapanor, to be known by the brand name Ibsrela. Tenapanor, a 50 mg. daily oral medication is approved for adults. It has not been approved for youth under the …

Continue reading

Phone Research: iSTEP Study for Mothers with Irritable Bowel Syndrome (IBS), Seattle Children’s Research Institute, September 2019

The following telephone research study seeking volunteers is being conducted by the Seattle Children’s Research Institute in Seattle, Washington, USA. It is open to women with a diagnosis of IBS and abdominal pain who are also parenting a child or children ages 5-10 who do not have abdominal pain. The study consists of  a 30 …

Continue reading

Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019 (HR 3396) Introduced in the U.S. House of Representatives.

The International Foundation for Functional Gastrointestinal Disorders (IFFGD) has announced that the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2019, also known as HR 3396 was introduced in the U.S. House of Representatives on June 20, 2019.  HR 3396 addresses public awareness efforts and research funding for functional gastrointestinal and motility disorders like …

Continue reading